ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,995.53
0.32%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. International Stem Cell Corporation (QB) (ISCO)

  7. International Stem Cell Corporation (QB) (ISCO) Noticias

ISCO

International Stem Cell (QB) (ISCO)

International Stem Cell Corporation (QB)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:ISCO
FechaHoraFuenteTítuloSímboloCompañía
13/11/202315:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ISCOInternational Stem Cell Corporation (QB)
08/11/202312:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ISCOInternational Stem Cell Corporation (QB)
27/09/202311:27Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:ISCOInternational Stem Cell Corporation (QB)
18/09/202307:01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ISCOInternational Stem Cell Corporation (QB)
21/06/202313:08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
16/06/202316:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
12/05/202315:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
28/04/202315:31Edgar (US Regulatory)Annual Report to Security Holders (ars)USOTC:ISCOInternational Stem Cell Corporation (QB)
30/03/202315:37Edgar (US Regulatory)Annual Report (10-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
27/04/202215:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ISCOInternational Stem Cell Corporation (QB)
26/06/202017:07Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ISCOInternational Stem Cell Corporation (QB)
13/05/202012:35Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
14/08/201916:07Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
29/04/201907:30InvestorsHub NewsWireInternational Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
16/04/201907:30InvestorsHub NewsWireInternational Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End ResultsUSOTC:ISCOInternational Stem Cell Corporation (QB)
07/03/201905:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:ISCOInternational Stem Cell Corporation (QB)
13/02/201907:30InvestorsHub NewsWireInternational Stem Cell Corporation Publishes Successful Results in Traumatic Brain InjuryUSOTC:ISCOInternational Stem Cell Corporation (QB)
15/01/201907:30InvestorsHub NewsWireInternational Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging BusinessUSOTC:ISCOInternational Stem Cell Corporation (QB)
05/12/201807:30InvestorsHub NewsWireInternational Stem Cell Corporation is Valued at $6.16 per Share by Edison Investment ResearchUSOTC:ISCOInternational Stem Cell Corporation (QB)
15/11/201807:30InvestorsHub NewsWireInternational Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018USOTC:ISCOInternational Stem Cell Corporation (QB)
05/11/201807:30InvestorsHub NewsWireInternational Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
30/10/201807:30InvestorsHub NewsWireInternational Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual MeetingUSOTC:ISCOInternational Stem Cell Corporation (QB)
08/10/201807:30InvestorsHub NewsWireInternational Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
02/10/201807:00InvestorsHub NewsWireInternational Stem Cell Corporation Raised Funds Through a Private Placement at Premium to MarketUSOTC:ISCOInternational Stem Cell Corporation (QB)
21/08/201806:00InvestorsHub NewsWireInternational Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic ProgramUSOTC:ISCOInternational Stem Cell Corporation (QB)
15/08/201806:00InvestorsHub NewsWireInternational Stem Cell Corp Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018USOTC:ISCOInternational Stem Cell Corporation (QB)
15/08/201805:49Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ISCOInternational Stem Cell Corporation (QB)
10/07/201806:00InvestorsHub NewsWireInternational Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical ProductsUSOTC:ISCOInternational Stem Cell Corporation (QB)
11/06/201806:00InvestorsHub NewsWireInternational Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
05/06/201806:00InvestorsHub NewsWireInternational Stem Cell Corporation to Launch Advanced Joint SupplementUSOTC:ISCOInternational Stem Cell Corporation (QB)
 Showing the most relevant articles for your search:USOTC:ISCO

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
NYSE
MRK
Merck
NYSE
JPM
JP Morgan Chase
FX
USDMXN
US Dollar vs MXN
FX
EURMXN
Euro vs MXN
AMEX
XLF
Financial Select Sector
AMEX
XLV
Health Care Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NYSE
BAC
Bank of America
PM
XAUUSD
Gold vs US Dollar
NYSE
CVX
Chevron
AMEX
SPY
SPDR S&P 500
NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados